BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37743782)

  • 1. De novo missense variants in ZBTB47 are associated with developmental delays, hypotonia, seizures, gait abnormalities, and variable movement abnormalities.
    Ward SK; Wadley A; Tsai CA; Benke PJ; Emrick L; Fisher K; Houck KM; Dai H; ; Guillen Sacoto MJ; Craigen W; Glaser K; Murdock DR; Rohena L; Diderich KEM; Bruggenwirth HT; Lee B; Bacino C; Burrage LC; Rosenfeld JA
    Am J Med Genet A; 2024 Jan; 194(1):17-30. PubMed ID: 37743782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.
    Muir AM; Gardner JF; van Jaarsveld RH; de Lange IM; van der Smagt JJ; Wilson GN; Dubbs H; Goldberg EM; Zitano L; Bupp C; Martinez J; Srour M; Accogli A; Alhakeem A; Meltzer M; Gropman A; Brewer C; Caswell RC; Montgomery T; McKenna C; McKee S; Powell C; Vasudevan PC; Brady AF; Joss S; Tysoe C; Noh G; Tarnopolsky M; Brady L; Zafar M; Schrier Vergano SA; Murray B; Sawyer L; Hainline BE; Sapp K; DeMarzo D; Huismann DJ; Wentzensen IM; Schnur RE; Monaghan KG; Juusola J; Rhodes L; Dobyns WB; Lecoquierre F; Goldenberg A; Polster T; Axer-Schaefer S; Platzer K; Klöckner C; Hoffman TL; MacArthur DG; O'Leary MC; VanNoy GE; England E; Varghese VC; Mefford HC
    Genet Med; 2021 May; 23(5):881-887. PubMed ID: 33473207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo variants in AGO1 recapitulate a heterogeneous neurodevelopmental disorder phenotype.
    Niu Y; Qian Q; Li J; Gong P; Jiao X; Mao X; Xiao B; Long L; Yang Z
    Clin Genet; 2022 Apr; 101(4):459-465. PubMed ID: 35060114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo variants in CNOT3 cause a variable neurodevelopmental disorder.
    Martin R; Splitt M; Genevieve D; Aten E; Collins A; de Bie CI; Faivre L; Foulds N; Giltay J; Ibitoye R; Joss S; Kennedy J; Kerr B; Kivuva E; Koopmans M; Newbury-Ecob R; Jean-Marçais N; Peeters EAJ; Smithson S; Tomkins S; Tranmauthem F; Piton A; van Haeringen A
    Eur J Hum Genet; 2019 Nov; 27(11):1677-1682. PubMed ID: 31201375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel de novo KDM5C variant in a female with global developmental delay and ataxia: a case report.
    Lippa NC; Barua S; Aggarwal V; Pereira E; Bain JM
    BMC Neurol; 2021 Sep; 21(1):358. PubMed ID: 34530748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
    Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
    Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.
    Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK
    J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo missense variants in exon 9 of SEPHS1 cause a neurodevelopmental condition with developmental delay, poor growth, hypotonia, and dysmorphic features.
    Mullegama SV; Kiernan KA; Torti E; Pavlovsky E; Tilton N; Sekula A; Gao H; Alaimo JT; Engleman K; Rush ET; Blocker K; Dipple KM; Fettig VM; Hare H; Glass I; Grange DK; Griffin M; Phornphutkul C; Massingham L; Mehta L; Miller DE; Thies J; Merritt JL; Muller E; Osmond M; Sawyer SL; Slaugh R; Hickey RE; Wolf B; ; ; Choudhary S; Simonović M; Zhang Y; Palculict TB; Telegrafi A; Carere DA; Wentzensen IM; Morrow MM; Monaghan KG; Yang J; Juusola J
    Am J Hum Genet; 2024 Apr; 111(4):778-790. PubMed ID: 38531365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues.
    Smits DJ; Schot R; Popescu CA; Dias KR; Ades L; Briere LC; Sweetser DA; Kushima I; Aleksic B; Khan S; Karageorgou V; Ordonez N; Sleutels FJGT; van der Kaay DCM; Van Mol C; Van Esch H; Bertoli-Avella AM; Roscioli T; Mancini GMS
    Hum Genet; 2023 Jul; 142(7):949-964. PubMed ID: 37198333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures.
    Nakashima M; Tohyama J; Nakagawa E; Watanabe Y; Siew CG; Kwong CS; Yamoto K; Hiraide T; Fukuda T; Kaname T; Nakabayashi K; Hata K; Ogata T; Saitsu H; Matsumoto N
    J Hum Genet; 2019 Apr; 64(4):313-322. PubMed ID: 30655572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia.
    Khan K; Zech M; Morgan AT; Amor DJ; Skorvanek M; Khan TN; Hildebrand MS; Jackson VE; Scerri TS; Coleman M; Rigbye KA; Scheffer IE; Bahlo M; Wagner M; Lam DD; Berutti R; Havránková P; Fečíková A; Strom TM; Han V; Dosekova P; Gdovinova Z; Laccone F; Jameel M; Mooney MR; Baig SM; Jech R; Davis EE; Katsanis N; Winkelmann J
    Genet Med; 2019 Nov; 21(11):2532-2542. PubMed ID: 31036918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo variants in CACNA1E found in patients with intellectual disability, developmental regression and social cognition deficit but no seizures.
    Royer-Bertrand B; Jequier Gygax M; Cisarova K; Rosenfeld JA; Bassetti JA; Moldovan O; O'Heir E; Burrage LC; Allen J; Emrick LT; Eastman E; Kumps C; Abbas S; Van Winckel G; ; Chabane N; Zackai EH; Lebon S; Keena B; Bhoj EJ; Umair M; Li D; Donald KA; Superti-Furga A
    Mol Autism; 2021 Oct; 12(1):69. PubMed ID: 34702355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited and de novo variants extend the etiology of
    Hunter JM; Massingham LJ; Manickam K; Bartholomew D; Williamson RK; Schwab JL; Marhabaie M; Siemon A; de Los Reyes E; Reshmi SC; Cottrell CE; Wilson RK; Koboldt DC
    Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 35091509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel
    Kaiwar C; Zimmermann MT; Ferber MJ; Niu Z; Urrutia RA; Klee EW; Babovic-Vuksanovic D
    Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 28963436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare and de novo duplications containing TCF20 are associated with a neurodevelopmental disorder.
    Lévy J; Cogan G; Maruani A; Maillard A; Dupont C; Drunat S; Rachid M; Atzori P; Delorme R; Jeyarajah S; Isidor B; Pichon O; Moradkhani K; Verloes A; Tabet AC
    Clin Genet; 2022 Mar; 101(3):364-370. PubMed ID: 34904221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy.
    Usmani MA; Ahmed ZM; Magini P; Pienkowski VM; Rasmussen KJ; Hernan R; Rasheed F; Hussain M; Shahzad M; Lanpher BC; Niu Z; Lim FY; Pippucci T; Ploski R; Kraus V; Matuszewska K; Palombo F; Kianmahd J; ; Martinez-Agosto JA; Lee H; Colao E; Motazacker MM; Brigatti KW; Puffenberger EG; Riazuddin SA; Gonzaga-Jauregui C; Chung WK; Wagner M; Schultz MJ; Seri M; Kievit AJA; Perrotti N; Wassink-Ruiter JSK; van Bokhoven H; Riazuddin S; Riazuddin S
    Am J Hum Genet; 2021 Jul; 108(7):1330-1341. PubMed ID: 34102099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo variants in
    Tanaka AJ; Cho MT; Willaert R; Retterer K; Zarate YA; Bosanko K; Stefans V; Oishi K; Williamson A; Wilson GN; Basinger A; Barbaro-Dieber T; Ortega L; Sorrentino S; Gabriel MK; Anderson IJ; Sacoto MJG; Schnur RE; Chung WK
    Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HECW2-related disorder in four Japanese patients.
    Yanagishita T; Hirade T; Shimojima Yamamoto K; Funatsuka M; Miyamoto Y; Maeda M; Yanagi K; Kaname T; Nagata S; Nagata M; Ishihara Y; Miyashita Y; Asano Y; Sakata Y; Kosaki K; Yamamoto T
    Am J Med Genet A; 2021 Oct; 185(10):2895-2902. PubMed ID: 34047014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.